Table 2 Summary of baseline patient characteristics in Maze + MVS with MVS alone in surgical treatment for AF
First author | Age | Male (%) | LVEF (%) | LAD (mm) | AF duration (mo) | Mitral stenosis(%) | Mitral regurgitation(%) | Permanent or persistent AF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | Maze + MVS | MVS | |
Deneke, T | 64.7 | 69.7 | 40.0 | 20.0 | 64.0 | 61.0 | 59.8 | 57.8 | 43.2 | 44.4 | 13.3 | 20.0 | 53.3 | 66.7 | 100.0 | 100.0 |
Akpinar, B | 53 ± 10 | 50 ± 8 | 60.1 | 73.5 | 55.2 ± 6.3 | 55.0 ± 8.1 | 62.5 ± 10.5 | 66.7 ± 9.0 | 19.9 ± 10.6 | 22.0 ± 13.9 | NR | NR | NR | NR | NR | NR |
Jessurun, E. R | 64 ± 12 | 64 ± 9 | 56.0 | 50.0 | 45.0 ± 15.0 | 45.0 ± 6.0 | 53.0 ± 9.0 | 56.0 ± 7.0 | NR | NR | NR | NR | NR | NR | 48.0 | 80.0 |
de Lima, G. G | 50.1 ± 15.3 | 50.1 ± 15.4 | 30.0 | 60.0 | 64.3 ± 7.0 | 64.0 ± 9.5 | 60.0 ± 16.0 | 62.0 ± 12.0 | 14.0 | 16.5 | 40.0 | 20.0 | 50.0 | 50.0 | 100.0 | 100.0 |
Abreu Filho, C. A | 55.4 ± 12.8 | 50.7 ± 9.7 | 33.3 | 42.9 | 62.8 ± 9.2 | 66.1 ± 10.5 | 61.1 ± 11.2 | 58.8 ± 4.7 | 66.1 ± 57.4 | 43.8 ± 28.5 | 61.9 | 64.2 | 38.1 | 35.8 | 100.0 | 100.0 |
Chevalier, P | 69.1 ± 6.2 | 66.3 ± 9.7 | 23.8 | 50.0 | 59.8 ± 8.5 | 61.3 ± 9.5 | 54.6 ± 10.9 | 52.6 ± 11.0 | 161.0 | 89.0 | 19.1 | 22.7 | 57.1 | 63.6 | 100.0 | 100.0 |
von Oppell, U. O | 66 ± 8 | 68 ± 9 | 33.0 | 56.0 | 52 ± 12 | 55 ± 16 | 52 ± 8 | 55 ± 8 | 84 ± 120 | 60 ± 48 | 8.0 | 0.0 | 63.0 | 60.0 | 91.7 | 88.0 |
Gillinov, A. M | 69.7 ± 10.4 | 69.4 ± 10.0 | 57.1 | 50.4 | 55.1 ± 7.6 | 56.5 ± 7.7 | NR | NR | NR | NR | NR | NR | 43.6 | 42.5 | 42.1 | 49.2 |
Wang, H | 55.92 ± 7.17 | 55.37 ± 7.67 | 29.2 | 41.0 | 55 ± 4 | 54 ± 3 | 51.8 ± 8.0 | 51.4 ± 8.4 | NR | NR | 95.3 | 93.8 | 76.8 | 80.0 | 100.0 | 100.0 |